Avantor's Revival turnaround arrived ahead of schedule as its VWR distribution business unexpectedly returned to positive organic growth, powering a 10.9% EPS beat and 5.1% revenue beat that forced management to raise full-year earnings guidance by three cents. The lab products company punched through analyst skepticism by proving its turnaround efforts are stabilizing competitive footing, not just treading water.
Avantor :
AVTR
AVTR
Stock Data
$13.93
$0.16 (1.16%)
Asset Type
Common Stock
Exchange
NYSE
Currency
USD
Country
USA
Sector
HEALTHCARE
Industry
MEDICAL INSTRUMENTS & SUPPLIES
Avantor Inc is a key player in providing essential products and services across various sectors including biopharma, healthcare, education, government, and advanced technologies. With a global footprint, Avantor delivers a wide range of offerings from high-purity chemicals, lab supplies, and customized materials to sophisticated equipment like filtration systems and ultra-low-temperature freezers. Beyond products, it offers vital services such as onsite lab management, clinical support, and biopharmaceutical development. Founded in 1904 and based in Radnor, Pennsylvania, Avantor stands as a backbone for scientific and technological advancements.
Latest Activity
All Avantor Articles
9 Articles